Related Experiment Video
Updated: Feb 12, 2026

Murine Dermal Fibroblast Isolation by FACS
Published on: January 7, 2016
Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression
Ming Keat Sng1,2, Jeremy Soon Kiat Chan1, Ziqiang Teo1
11School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551 Singapore.
Abstract:
Connective tissue diseases of the skin are characterized by excessive collagen deposition in the skin and internal organs. Fibroblasts play a pivotal role in the clinical presentation of these conditions. Nuclear receptor peroxisome-proliferator activated receptors (PPARs) are therapeutic targets for dermal fibrosis, but the contribution of the different PPAR subtypes are poorly understood. Particularly, the role of fibroblast PPARβ/δ in dermal fibrosis has not been elucidated. Thus, we generated a mouse strain with selective deletion of PPARβ/δ in the fibroblast (FSPCre-Pparb/d-/-) and interrogated its epidermal and dermal transcriptome profiles. We uncovered a downregulated gene, leucine-rich alpha-2-glycoprotein-1 (Lrg1), of previously unknown function in skin development and architecture. Our findings suggest that the regulation of Lrg1 by PPARβ/δ in fibroblasts is an important signaling conduit integrating PPARβ/δ and TGFβ1-signaling networks in skin health and disease. Thus, the FSPCre-Pparb/d-/- mouse model could serve as a novel tool in the current gunnery of animal models to better understand dermal fibrosis.
Insights
This study reveals how fibroblast PPARβ/δ regulates LRG1, a key gene in skin health and dermal fibrosis. This finding offers new insights into connective tissue diseases and potential therapeutic targets.
Area of Science:
- Dermatology
- Molecular Biology
- Genetics
Background:
- Connective tissue diseases involve excessive collagen deposition, impacting skin and organs.
- Fibroblasts are crucial in the pathology of these conditions.
- Peroxisome-proliferator activated receptors (PPARs) are therapeutic targets for dermal fibrosis, but subtype roles are unclear.
Purpose of the Study:
- To investigate the role of fibroblast PPARβ/δ in dermal fibrosis.
- To identify novel genes regulated by fibroblast PPARβ/δ in skin.
Main Methods:
- Generated a fibroblast-specific PPARβ/δ knockout mouse model (FSPCre-Pparb/d-/-).
- Analyzed epidermal and dermal transcriptome profiles of the knockout mice.
Main Results:
- Discovered downregulated leucine-rich alpha-2-glycoprotein-1 (LRG1) in knockout mice.
- Identified LRG1 as a novel gene in skin development and architecture.
- Demonstrated that fibroblast PPARβ/δ regulates LRG1, integrating PPARβ/δ and TGFβ1 signaling.
Conclusions:
- Fibroblast PPARβ/δ plays a significant role in skin homeostasis and dermal fibrosis.
- LRG1 is a novel downstream target of PPARβ/δ in fibroblasts.
- The FSPCre-Pparb/d-/- mouse model is a valuable tool for studying dermal fibrosis.
More Related Videos
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Antibiotic Selection
Introduction to Fibroblasts
What is Natural Selection?
Cystic Fibrosis: Management
Sinus disease and chronic...

